We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-0.34%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$55.7B
AUM Growth
-$11.4B
Cap. Flow
-$9.72B
Cap. Flow %
-17.45%
Top 10 Hldgs %
9.49%
Holding
4,137
New
382
Increased
1,324
Reduced
1,495
Closed
773

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$397M
2
YHOO
Yahoo Inc
YHOO
+$342M
3
BAC icon
Bank of America
BAC
+$322M
4
C icon
Citigroup
C
+$260M
5
BKNG icon
Booking.com
BKNG
+$219M

Sector Composition

Rank Sector Weight
1 Healthcare 13.78%
2 Technology 11.11%
3 Financials 10%
4 Consumer Discretionary 8.83%
5 Communication Services 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TYPE
1476
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$3.56M 0.01%
148,976
+13,481
+10% +$314K
APA icon
1477
CALL
APA Corp
APA
$14.6B
$3.56M 0.01%
73,000
-276,000
-79% -$11.5M
CTRN icon
1478
Citi Trends
CTRN
$588M
$3.56M 0.01%
199,831
+39,017
+24% +$729K
TSRO
1479
DELISTED
TESARO, Inc.
TSRO
$3.56M 0.01%
80,875
-112,433
-58% -$4.51M
FIX icon
1480
Comfort Systems
FIX
$56.5B
$3.56M 0.01%
111,961
-251
-0.2% -$7.1K
XOMA
1481
DELISTED
Xoma
XOMA
$3.55M 0.01%
229,806
+56,557
+33% +$1.02M
CVT
1482
DELISTED
CVENT, INC.
CVT
$3.55M 0.01%
165,890
+48,067
+41% +$1.13M
IRWD icon
1483
Ironwood Pharmaceuticals
IRWD
$709M
$3.53M 0.01%
385,664
+39,009
+11% +$322K
BGFV
1484
DELISTED
Big 5 Sporting Goods
BGFV
$3.53M 0.01%
317,409
+119,006
+60% +$1.39M
NYT icon
1485
New York Times
NYT
$11.1B
$3.52M 0.01%
282,722
-97,647
-26% -$1.24M
SWBI icon
1486
CALL
Smith & Wesson
SWBI
$602M
$3.52M 0.01%
172,122
WIRE
1487
DELISTED
Encore Wire Corp
WIRE
$3.52M 0.01%
90,411
+2,820
+3% +$102K
TD icon
1488
Toronto Dominion Bank
TD
$198B
$3.52M 0.01%
81,564
-23,778
-23% -$918K
NJ
1489
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
$3.51M 0.01%
204,799
+85,708
+72% +$1.46M
PAYX icon
1490
Paychex
PAYX
$44.4B
$3.51M 0.01%
64,944
+19,458
+43% +$980K
SSYS icon
1491
PUT
Stratasys
SSYS
$705M
$3.49M 0.01%
134,800
+96,200
+249% +$1.96M
MRO
1492
PUT
DELISTED
Marathon Oil Corporation
MRO
$3.49M 0.01%
313,400
-516,600
-62% -$4.83M
MX icon
1493
Magnachip Semiconductor
MX
$119M
$3.49M 0.01%
640,717
+188,922
+42% +$879K
ILG
1494
PUT
DELISTED
ILG, Inc Common Stock
ILG
$3.47M 0.01%
+240,000
New +$3.11M
KMX icon
1495
PUT
CarMax
KMX
$9.08B
$3.46M 0.01%
67,800
+15,600
+30% +$736K
ROCK icon
1496
Gibraltar Industries
ROCK
$1.37B
$3.46M 0.01%
120,967
-4,543
-4% -$106K
ALK icon
1497
CALL
Alaska Air
ALK
$4.87B
$3.44M 0.01%
42,000
-5,800
-12% -$429K
IMPR
1498
DELISTED
IMPRIVATA, INC COM
IMPR
$3.44M 0.01%
272,662
-2,290
-0.8% -$26.1K
ADBE icon
1499
Adobe
ADBE
$108B
$3.44M 0.01%
36,710
-628,279
-94% -$54.5M
GWPH
1500
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$3.44M 0.01%
47,700

Similar funds

David Shaw's Q1 2016 Portfolio in Review

As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.

  • David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
  • David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
  • David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
  • David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
  • David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
  • David Shaw opened 382 new positions and closed 773 in Q1 2016.
  • David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.

Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.